Search results for "From ACP Internist"
SGLT-2 inhibitors associated with lower risk of gout vs. GLP-1 receptor agonists
In a large, propensity-matched study, adult patients with type 2 diabetes who were newly prescribed a sodium-glucose cotransporter-2 (SGLT-2) inhibitor had a lower rate of incident gout than those newly prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist.
https://diabetes.acponline.org/archives/2020/02/14/7.htm
14 Feb 2020
Treating skin ulcers in the office
The right outpatient care, dressings, and tests for diabetic foot ulcers were reviewed by a certified wound specialist physician in June ACP Internist coverage.
https://diabetes.acponline.org/archives/2020/06/12/8.htm
12 Jun 2020
ADA conference coverage on kidneys, weight, and insulin switches
The American Diabetes Association (ADA) 2020 Scientific Sessions were held virtually in June and covered in the August ACP Hospitalist and September ACP Internist.
https://diabetes.acponline.org/archives/2020/09/11/8.htm
11 Sep 2020
Once-weekly insulin had similar effects to daily insulin in type 2 diabetes, industry-funded trial finds
HbA1c levels improved by more than a point in insulin-naive patients with inadequately controlled type 2 diabetes who were randomized to a weekly 70-U dose of an investigational insulin.
https://diabetes.acponline.org/archives/2020/10/09/8.htm
9 Oct 2020
Regular use of PPIs linked to increased risk of type 2 diabetes
In an analysis of the Nurses' Health and Health Professionals studies, regular users of proton-pump inhibitors (PPIs) had a 24% higher risk of diabetes than nonusers, with longer duration of use associated with greater risk.
https://diabetes.acponline.org/archives/2020/10/09/9.htm
9 Oct 2020
Group-based lifestyle intervention reduced risk of type 2 diabetes
Participants in the Norfolk Diabetes Prevention Study who underwent multiple educational group sessions that included 50-minute sessions of supervised physical activity had significantly lower odds of type 2 diabetes during a mean follow-up of two years compared to those who received usual care.
https://diabetes.acponline.org/archives/2020/11/13/9.htm
13 Nov 2020
Type of insulin may affect hypoglycemia rates in older adults with type 2 diabetes, study finds
The risk of hospital visits for hypoglycemia was lower with long-acting insulin analogs versus neutral protamine Hagedorn (NPH) insulin in a retrospective study of Medicare patients.
https://diabetes.acponline.org/archives/2021/03/12/8.htm
12 Mar 2021
Watch out for NAFLD, and help patients get more exercise
The April ACP Internist looked at two issues related to diabetes— the high prevalence of nonalcoholic fatty liver disease (NAFLD) and how some internists have succeeded in getting their patients to exercise more.
https://diabetes.acponline.org/archives/2021/04/09/6.htm
9 Apr 2021
Racial, economic disparities found in use of SGLT2 inhibitors
Although use of sodium-glucose cotransporter-2 (SGLT2) inhibitors rose overall between 2015 and 2019, patients who were Black, Asian, female, or with lower household income had lower rates of prescriptions for the drug class than others with type 2 diabetes.
https://diabetes.acponline.org/archives/2021/05/14/8.htm
14 May 2021
New recommendations advise on adding SGLT-2 inhibitors and GLP-1 receptor agonists
A new guideline from The BMJ strongly recommends sodium-glucose cotransporter-2 (SGLT-2) inhibitors for patients with diabetes and established cardiovascular and chronic kidney disease, in addition to offering weaker support for starting glucagon-like peptide-1 (GLP-1) receptor agonists in this same patient population.
https://diabetes.acponline.org/archives/2021/06/11/7.htm
11 Jun 2021